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Abstract
Background:  IL12A has been implicated in T-cell development and may thus influence the
development of atopy and allergic diseases.
Methods:  We tested for association between four linkage disequilibrium (LD)-tagging SNPs
(rs2243123, rs2243151, rs668998, and rs17826053) in IL12A and asthma and allergy-related (serum
total and allergen-specific IgE, and skin test reactivity [STR] to two common allergens) phenotypes
in two samples: 417 Costa Rican children with asthma and their parents, and 470 families of 503
white children in the Childhood Asthma Management Program (CAMP). The analysis was
conducted using the family-based association test (FBAT) statistic implemented in the PBAT
program.
Results: Among Costa Rican children with asthma, homozygosity for the minor allele of each of
two SNPs in IL12A (rs2243123 and rs2243151) was associated with increased risks of STR to
American cockroach (P ≤ 0.03 for both SNPs), STR to German cockroach (P ≤ 0.01 for both SNPs),
and having a positive IgE to German cockroach (P < 0.05 for both SNPs). Among children in CAMP,
homozygosity for the minor allele of SNP rs2243151 in IL12A was inversely associated with STR to
German cockroach (P = 0.03) and homozygosity for the minor allele of SNP rs17826053 in IL12A
was associated with increased risks of STR to American cockroach (P = 0.01) and STR to German
cockroach (P = 0.007). There was no significant association between any SNP in IL12A and asthma,
STR to dust mite, or total IgE in Costa Rica or CAMP.
Conclusion:  Our findings suggest that variants in IL12A  influence cockroach allergy among
children with asthma.
Published: 31 July 2008
Clinical and Molecular Allergy 2008, 6:6 doi:10.1186/1476-7961-6-6
Received: 17 June 2008
Accepted: 31 July 2008
This article is available from: http://www.clinicalmolecularallergy.com/content/6/1/6
© 2008 Pistiner et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Molecular Allergy 2008, 6:6 http://www.clinicalmolecularallergy.com/content/6/1/6
Page 2 of 7
(page number not for citation purposes)
Introduction
Interleukin 12 (IL12), an immunomodulatory cytokine
secreted by antigen presenting cells, is critical for differen-
tiation of T helper (Th)1 and Th2 lymphocytes. [1,2]. IL12
has been shown to augment the growth of activated T- and
natural killer (NK)-cells [3,4], stimulate interferon
gamma (IFN-γ) production by T-cells and NK cells[4,5],
and suppress the expansion of Th2 cell clones [4,6].
IL12 may be implicated in the pathogenesis of asthma.
Expression of IL12 is lower in airway biopsies and periph-
eral blood eosinophils of asthmatics than in controls
[4,7]. Similarly, production of IL12 and IL12-induced
release of IFN-γ are reduced in subjects with atopic asthma
compared to controls [4,8]. IL12 is a disulfide-linked het-
erodimer comprised of IL12B (p40) and IL12A (p35)
[2,9]. mRNAs for p40 and p35 are both induced upon
activation and their co-expression is necessary for secre-
tion of biologically activated IL12 [1,2].
The gene for IL12A (IL12A) is located on chromosome
3p12-13.2 [10], a genomic region linked to asthma and its
intermediate phenotypes [11]. To date, there has been no
association study of IL12A and asthma or allergies. Thus,
we performed a study of association between variants in
IL12A and asthma and allergy-related phenotypes in fam-
ilies of children with asthma in an ongoing study of the
Genetics of Asthma in Costa Rica. We then attempted to
replicate positive findings in Costa Rica in families of
white children with asthma in the Childhood Asthma
Management Program (CAMP).
Subjects and methods
Study populations
Subject recruitment for the Genetics of Asthma in Costa
Rica Study has been previously described in detail [12].
The population of the Central Valley of Costa Rica is a
genetic isolate of mixed Spanish and Amerindian ancestry
[13] with a prevalence of asthma that ranks among the
highest in the world [14]. In brief, Costa Rican schoolchil-
dren aged 6–14 years were recruited from February of
2001 to March of 2005. Index children were eligible for
inclusion in the study (along with their parents) if they
had asthma (defined as physician-diagnosed asthma and
at least 2 respiratory symptoms or asthma attacks in the
previous year) and high probability of having at least 6
great-grandparents born in the Central Valley of Costa
Rica [12,15]. Of the 439 participating children, 426 had
DNA that passed quality control and are included in this
analysis along with their parents. Index children com-
pleted a protocol that included a questionnaire (slightly
modified from one used for the Collaborative Study on
the Genetics of Asthma) [16], allergy skin testing, and col-
lection of blood samples (for DNA extraction and meas-
urement of serum total and allergen-specific IgE). Written
parental consent was obtained for participating children,
for whom written assent was also obtained. The study was
approved by the Institutional Review Boards of the Hospi-
tal Nacional de Niños (San José, Costa Rica) and Brigham
and Women's Hospital (BWH, Boston, Massachusetts).
Subject recruitment and collection of phenotypic data for
CAMP have been previously described in detail [17,18].
CAMP was a multicenter clinical trial of the effects of anti-
inflammatory medications in children with mild to mod-
erate asthma. Participating children had asthma defined
by symptoms greater than 2 times per week, use of an
inhaled bronchodilator at least twice weekly or use of
daily medication for asthma, and increased airway
responsiveness to methacholine (PC20  ≤ 12.5 mg/ml)
[17,18]. Of the 1,041 children enrolled in the original
clinical trial, 968 children and 1,518 of their parents con-
tributed DNA samples. Because of small sample size for
other ethnic groups, this analysis was restricted to 483
nuclear families of white children. Questionnaire data
was collected at baseline and during the course of the
four-year clinical trial, and blood samples and house dust
samples were collected at baseline [17,18]. Written
informed consent was obtained from parents of partici-
pating children. CAMP was approved by the Institutional
Review Boards of BWH and the other participating cent-
ers.
Allergy Skin Testing
In Costa Rica, allergy skin testing was performed accord-
ing to the ISAAC protocol [19]. In addition to histamine
and saline controls, the following antigens were applied
to the volar surface of the forearm: Dermatophagoides (D.)
pteronyssinus, D. farinae, Blatella (B.) germanica (German
cockroach),  Periplaneta (P.) americana (American cock-
roach), cat dander, dog dander, mixed grass pollen, mixed
tree pollen, and Alternaria tenuis. In CAMP, histamine,
saline control, and the following allergens were applied to
the volar surface of the forearm: P. americana,  B. ger-
manica, D. pteronyssinus, D. farinae, cat dander, dog dan-
der, penicillium mix, aspergillus mix, Timothy grass, and
short ragweed [17]. In Costa Rica and in CAMP, a test was
considered positive if the maximum diameter of the
wheal was ≥ 3 mm after subtraction of the maximum
diameter of the negative control. Because of considera-
tions of statistical power (given the known prevalence of
skin test reactivity [STR] to each of the allergens tested in
Costa Rica and CAMP), this analysis included only data
for STR to American cockroach, STR to German cock-
roach, and STR to D. pteronyssinus.
Measurement of Serum Total and Allergen-Specific IgE
In Costa Rica, serum total IgE and IgE specific to two com-
mon allergens (D. pteronyssinus [heretofore called dust
mite] and B. germanica [German cockroach]) were meas-Clinical and Molecular Allergy 2008, 6:6 http://www.clinicalmolecularallergy.com/content/6/1/6
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ured using the UniCAP 250 system (Pharmacia & Upjohn,
Kalamazoo, MI), with samples measured in duplicate. IgE
specific to each allergen was considered positive if >= 0.35
IU/ml. In CAMP, serum total IgE was measured by radio-
immunosorbent assays during the screening sessions.
Serum allergen-specific IgE was not measured in CAMP.
In both Costa Rica and CAMP, serum total IgE was trans-
formed to a log10 scale for data analysis.
Genotypic data
In Costa Rica and CAMP, genotyped markers were
selected using a linkage disequilibrium (LD)-tagging algo-
rithm for IL12A  and its 5-kb flanks. Of the 5 SNPs
selected, 4 were polymorphic in Costa Rica and were suc-
cessfully genotyped; these 4 SNPs capture ≥ 93% of the
HapMap SNPs in IL12A in CEPH (Centre d'etude du pol-
ymorphisme humain) trios at an r2 ≥ 0.8 for a minor allele
frequency (MAF) of 0.1.
In Costa Rica and CAMP, SNPs were genotyped using an
Illumina Beadstation 500G system (San Diego, CA) or the
Sequenom MassArray system (San Diego, CA). Duplicate
genotyping was performed on approximately 5% of the
sample to assess genotype reproducibility. No discordan-
cies were found for any of the assays. All loci had > 98%
genotyping completion rate.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) was tested in paren-
tal data by using a χ2 goodness-of-fit test, and deviations
from Mendelian inheritance were tested with PedCheck
[20]. Genotypes of families with Mendelian inconsisten-
cies were set to missing. Estimates of D' and R2 were
obtained from Haploview v3.11 [21].
All analyses were performed assuming additive, domi-
nant, and recessive genetic models. In both cohorts, SNPs
and haplotypes were tested for association with asthma
and allergy-related phenotypes using the family-based
association test statistic implemented in PBAT version
v3.2 [22]. Consistent with our previous work, all analyses
of quantitative phenotypes were adjusted for age and gen-
der. Results were considered replicated at the locus level if
P < 0.05 for the same phenotype under the same genetic
model in both Costa Rica and CAMP.
Results
Of 426 Costa Rican families, 9 were removed because of
Mendelian inconsistencies, leaving 417 children and their
parents. Of 483 nuclear families of white children in
CAMP, 13 were removed because of Mendelian inconsist-
encies, leaving 470 families (and 503 children). All SNPs
were HWE in parental genotypes in Costa Rica and CAMP.
Table 1 demonstrates the baseline characteristics of index
children with asthma in Costa Rica and index white (non-
Hispanic) children with asthma in CAMP. The distribu-
tion of age, gender, and serum total IgE was similar in the
Costa Rican and CAMP populations. However, estimates
of the prevalence of STR to either American or German
cockroach and the prevalence of STR to dust mite were
higher in Costa Rica than in CAMP.
The MAFs and the LD patterns for the SNPs of interest in
IL12A were similar in the Costa Rican and CAMP popula-
tions (Table 2 and Figure 1)[23], and not significantly dif-
ferent from the MAF of these SNPs in CEPH trios (Centre
d'etude du polymorphisme humain -a population of
northern and western European ancestry in Utah).
Table 3 shows the results of the family-based analysis of
association between SNPs in IL12A and: a) STR to the two
allergens tested (American cockroach and German cock-
roach) in Costa Rica and CAMP, and b) a positive IgE to
German cockroach in Costa Rica (as this trait was not
measured in CAMP). Among Costa Rican children with
asthma, homozygosity for the minor allele of each of two
Table 1: Baseline Characteristics of Children with Asthma in Costa Rica and White Children with Asthma in CAMP
Variable Costa Rica CAMP
N = 417 N = 503
Male gender (n, %) 260 (62.4) 312 (62.0)
Age in years (median,
interquartile range)
8.7 (7.7–10.4) 8.6 (7.0–10.5)
STR to B. germanica (n, %) 220 (53.0) 130 (25.8)
STR to P. americana (n, %) 228 (54.9) 108 (21.5)
STR to D. pteronyssinus (%) 326 (79.0) 226 (45.0)
Positive IgE to B. germanica (n, %) 174 (41.7)
Positive IgE to D. pteronyssinus (n, %) 319 (76.5)
Total serum IgE, IU/ml
(median, interquartile range)
414 (117–962) 399 (159–1066)
STR = skin test reactivity.
In Costa Rica, a positive IgE to either B. germanica or D. pteronyssinus was defined as a value >= 0.35 IU/ml. Allergen-specific IgE was not measured 
in CAMP.Clinical and Molecular Allergy 2008, 6:6 http://www.clinicalmolecularallergy.com/content/6/1/6
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SNPs (rs2243123 and rs2243151) was associated with
increased risks of STR to American cockroach, STR to Ger-
man cockroach, and a positive IgE to German cockroach
(consistent with a recessive genetic model). Similar results
were obtained under an additive genetic model, with the
exception of the association between the minor allele of
SNP rs2243123 and STR to German cockroach. Among
children in CAMP, homozygosity for the minor allele of
SNP rs2243151 was associated with reduced risk of STR to
German cockroach but homozygosity for the minor allele
of SNP rs17826053 was associated with increased risks of
STR to American cockroach and STR to German cock-
roach. Although there was no association between SNP
rs17826053 and STR to either American or German cock-
roach in Costa Rica, the frequency of the minor allele of
this SNP was lower in Costa Rica (0.08) than in CAMP
(0.14, see Table 2). Results of the family-based analysis of
haplotypes within IL12A were consistent with and did not
provide additional information to that gained by the anal-
ysis of SNPs (data not shown).
There was no significant association between any of the
SNPs in IL12A and asthma, total IgE, STR to dust mite, or
IgE to dust mite (Table 4).
Discussion
Among children with asthma in two ethnically distinct
cohorts, SNPs in IL12A were associated with an increased
risk of sensitization to cockroach but not with asthma or
other objective markers of atopy (serum total IgE, STR or
IgE to dust mite). The association between IL12A poly-
morphisms and cockroach allergy but not asthma is con-
sistent with results from human studies of recombinant
IL12 [24].
To our knowledge, this is the first study to examine the
association between polymorphisms in IL12 A and
asthma and allergy-related phenotypes. Strengths of this
study include its family-based design (which eliminates
concerns for population stratification) and the relatively
large sample size and availability of objectively measured
allergy-related phenotypes for each of the two cohorts
included.
We have previously demonstrated that the genomic
regions that influence sensitization to cockroach differ
from those that influence sensitization to dust mite in
Costa Rica [25]. Thus, our findings for IL12A may be due
to a more marked influence of variants in this gene on
cockroach sensitization than on other allergy phenotypes
among children with asthma. Prior genetic predisposition
to cockroach sensitization has been previously demon-
strated for variants in the genes for HLA-DRB1*01 and
HLA-DRB1*02 in Hutterite and African-American popu-
lations [26]. Of note, sensitization to cockroach has been
shown to be associated with disease severity among chil-
dren with asthma, particularly in the presence of high lev-
els of cockroach allergen [27].
As with any genetic association study, type I (false posi-
tive) and type II (false negative) results should be consid-
ered. With regard to potential type I error, the observed
association between variants in IL12A and cockroach sen-
sitization (assessed in two different ways in Costa Rica
[measurement of specific IgE and STR]) was consistent at
the gene (locus) level in the two populations studied. At
the SNP level, the observed association between the
minor allele of SNP rs2243151 and cockroach sensitiza-
tion in Costa Rica would remain significant even after an
stringent Bonferroni correction for multiple testing (P <
0.001 or 0.05/48 [3 (number of genetic models] * 4
(number of SNPs tested) * 4 (number of distinct pheno-
types, given the correlation between measures of both
cockroach and dust mite sensitization) under a recessive
genetic model. The consistency of the positive association
between SNP rs2243151 and two measures of cockroach
sensitization in the same genetic model in Costa Rica also
decreases the likelihood that this is a false positive associ-
ation. With regard to potential type II error, differences in
the prevalence of sensitization to cockroach between
Table 2: Allelic Frequencies of Genotyped Polymorphisms in 
IL12A
SNP (dbSNP
reference number)
Minor allele Minor allele frequency
Costa Rica CAMP
rs2243123 C 0.27 0.27
rs2243151 T 0.39 0.39
rs668998 G 0.49 0.42
rs17826053 G 0.08 0.14
Pairwise (r2) Linkage Disequilibrium Plots for IL12A in Par- ents of Index Children in A) Costa Rica and B) CAMP Figure 1
Pairwise (r2) Linkage Disequilibrium Plots for IL12A 
in Parents of Index Children in A) Costa Rica and B) 
CAMP.Clinical and Molecular Allergy 2008, 6:6 http://www.clinicalmolecularallergy.com/content/6/1/6
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study populations may have resulted in reduced power to
detect associations in CAMP and thus lack of replication
for some of our findings in Costa Rica. Conversely, the
discrepant findings for SNP rs17826053 may reflect
reduced statistical power due to a low minor allele fre-
quency for this variant in Costa Rica.
LD with variants in adjacent genes is an unlikely explana-
tion for our findings because the closest gene on either
flank of IL12A  (schwannomin interacting protein 1
[SCHIP1]) is located ~100 kb away. On the other hand,
LD with other (non-genotyped) variants in IL12A could
partly explain our results. To begin to examine this ques-
tion, we attempted to genotype a coding SNP in IL12A
that has been validated in dbSNP build 129 (rs1042155).
However, this variant was monomorphic in Costa Rica.
While the observed association between SNP rs2243151
and sensitization to German cockroach was significant in
both cohorts under a recessive genetic model, it was not in
the same direction across samples (positive in Costa Rica,
negative or inverse in CAMP). Given that at least one
other SNP was associated with an increased risk of STR to
cockroach in CAMP, the "flip-flop" association for SNP
rs2243151 may be due to subtle differences in LD patterns
for IL12A or unmeasured gene-by-gene or gene-by-envi-
ronment interactions in Costa Rica and/or CAMP [28].
Because of the small number of children with significant
exposure to cockroach allergen in the Central Valley of
Costa Rica, we had very limited power to assess gene-by-
cockroach allergen interactions.
In summary, this study demonstrates that polymorphisms
in IL12A are associated with sensitization to cockroach
among children with asthma. Definitive identification of
the functional SNPs responsible for this association will
require further study in our cohorts and in other popula-
tions.
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